SwanBio Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- SwanBio Therapeutics's estimated annual revenue is currently $3.3M per year.
- SwanBio Therapeutics's estimated revenue per employee is $77,500
- SwanBio Therapeutics's total funding is $52M.
Employee Data
- SwanBio Therapeutics has 43 Employees.
- SwanBio Therapeutics grew their employee count by -12% last year.
SwanBio Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Staff | Reveal Email/Phone |
2 | VP Tech Ops and Quality | Reveal Email/Phone |
3 | VP Clinical Operations | Reveal Email/Phone |
4 | VP, Legal and Intellectual Property | Reveal Email/Phone |
5 | SVP Program Development | Reveal Email/Phone |
6 | VP Vector Engineering and Bioassay | Reveal Email/Phone |
7 | Head Portfolio Development | Reveal Email/Phone |
8 | General Counsel & Head Intellectual Property | Reveal Email/Phone |
9 | Director, Research Operations | Reveal Email/Phone |
10 | Director Quality Assurance | Reveal Email/Phone |
SwanBio Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is SwanBio Therapeutics?
With offices in Philadephia and Boston, SwanBio Therapeutics is developing leading-edge therapies to deliver dramatic clinical efficacy for the treatment of neurological diseases. We are driven by an unrelenting passion to solve difficult challenges, and a belief that meaningful discovery is borne of curiosity, collaboration, and compassion. Founded by proven industry leaders with a commitment to positively impacting the lives of people with neurological diseases, SwanBio merges clinical, scientific and drug commercialization expertise. To learn about career opportunities contact us at careers@swanbiotx.com.
keywords:N/A
$52M
Total Funding
43
Number of Employees
$3.3M
Revenue (est)
-12%
Employee Growth %
N/A
Valuation
N/A
Accelerator
SwanBio Therapeutics News
SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...
SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...
SwanBio Therapeutics is a gene therapy company that aims to bring life-changing treatments to people with devastating, inherited neurological...
SwanBio Therapeutics, a Bala Cynwyd, Pa.-based gene therapy company developing medicines to deliver clinical efficacy for the treatment of AMN and other neurological diseases, completed a $52m expanded Series A financing. Syncona Ltd. and Partners Innovation Fund made a $20m investment as part ...
Other Companies in Bala Cynwyd
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.9M | 46 | 24% | N/A |
#2 | $9.8M | 49 | 4% | N/A |
#3 | $13M | 50 | -2% | N/A |
#4 | $3.5M | 54 | 13% | N/A |
#5 | $8.5M | 55 | 41% | N/A |